Accuracy of the revised 2010 TNM classification in predicting the prognosis of patients treated for renal cell cancer in the north east of England

Journal of Clinical Pathology

Volumn 65, Issue 4, 2012, Pages 367-371

  Veeratterapillay, R ^a   Simren, R ^b   El Sherif, A ^b   Johnson, M I ^a   Soomro, N ^a   Heer, Rakesh ^a,c  

^a FREEMAN HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; ENGLAND; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84863417141     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200468     Document Type: Article

References (20)

1. Flocks RH, Kadesky MC. Malignant neoplasms of the kidney; an analysis of 353 patients followed five years or more. J Urol 1958;79:196-201.
2. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969;101:297-301.
3. Javidan J, Stricker HJ, Tamboli P, et al. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. J Urol 1999;162:1277-81. (Pubitemid 29428562)
4. Moch H, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer 2000;89:604-14. (Pubitemid 30640107)
5. Frank I, Blute ML, Leibovich BC, et al. pT2 classification for renal cell carcinoma. Can its accuracy be improved? J Urol 2005;173:380-4.
6. Jung SJ, Ro JY, Truong LD, et al. Reappraisal of T3N0/NxM0 renal cell carcinoma: significance of extent of fat invasion, renal vein invasion, and adrenal invasion. Hum Pathol 2008;39:1689-94.
7. Greene FL, Gospodarowicz MK, Wittekend C. American Joint Committee on Cancer (AJCC) Staging Manual. 7th edn. Philadelphia: Springer, 2009.
8. Ficarra V, Martignoni G, Lohse C, et al. External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 2006;175:1235-9.
9. Kattan MW, Reuter V, Motzer RJ, et al. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001;166:63-7. (Pubitemid 32565343)
10. Motzer RJ, Mazumdar M, Bacik J, et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999;17:2530-40. (Pubitemid 29368255)
11. Eggener S. TNM staging for renal cell carcinoma: time for a new method. Eur Urol 2010;58:517-19; discussion 519-21.
12. Kim SP, Alt AL, Weight CJ, et al. Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort. J Urol 2011;185:2035-9.
13. Novara G, Ficarra V, Antonelli A, et al. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 2010;58:588-95.
14. Lee C, You D, Park J, et al. Validation of the 2009 TNM classification for renal cell carcinoma: comparison with the 2002 TNM classification by concordance index. Korean J Urol 2011;52:524-30.
15. Gospodarowicz MK, Miller D, Groome PA, et al. The process for continuous improvement of the TNM classification. Cancer 2004;100:1-5. (Pubitemid 37553532)
16. Ficarra V, Galfano A, Guillé F, et al. A new staging system for locally advanced (pT3- 4) renal cell carcinoma: a multicenter European study including 2,000 patients. J Urol 2007;178:418-24. (Pubitemid 47030485)
17. Han KR, Bui MH, Pantuck AJ, et al. TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol 2003;169:899-904.
18. Thompson RH, Cheville JC, Lohse CM, et al. Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy. Cancer 2005;104:53-60. (Pubitemid 40847752)
19. Siemer S, Lehmann J, Loch A, et al. Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. J Urol 2005;173:33-7. (Pubitemid 39627666)
20. Gofrit ON, Shapiro A, Pizov G, et al. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients? J Urol 2007;177:1682-6. (Pubitemid 46560663)